BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 10826482)

  • 1. In vitro and in vivo responses to interleukin 12 are maintained until the late SIV infection stage but lost during AIDS.
    Villinger F; Bucur S; Chikkala NF; Brar SS; Bostik P; Mayne AE; Adams J; Lee ME; Novembre FJ; Gately MK; Ansari AA; Hillyer CD
    AIDS Res Hum Retroviruses; 2000 May; 16(8):751-63. PubMed ID: 10826482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of recombinant rhesus interleukin-12 during acute simian immunodeficiency virus (SIV) infection leads to decreased viral loads associated with prolonged survival in SIVmac251-infected rhesus macaques.
    Ansari AA; Mayne AE; Sundstrom JB; Bostik P; Grimm B; Altman JD; Villinger F
    J Virol; 2002 Feb; 76(4):1731-43. PubMed ID: 11799168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus.
    Shieh TM; Carter DL; Blosser RL; Mankowski JL; Zink MC; Clements JE
    J Neurovirol; 2001 Feb; 7(1):11-24. PubMed ID: 11519478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
    Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge.
    Dittmer U; Stahl-Hennig C; Coulibaly C; Nisslein T; Lüke W; Fuchs D; Bodemer W; Petry H; Hunsmann G
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1307-15. PubMed ID: 7782761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Model index observations in SIVmac251-infected rhesus macaques].
    Zhang Y; Wang J; Liu XM; Min FG; Guo PJ; Huang R
    Bing Du Xue Bao; 2014 Nov; 30(6):675-82. PubMed ID: 25868283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of IL-18 by SIV does not modify the outcome of the antiviral immune response.
    Giavedoni LD; Velasquillo MC; Parodi LM; Hubbard GB; Hodara VL
    Virology; 2002 Nov; 303(2):327-37. PubMed ID: 12490394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic response to lineage-non-specific (rrIL-3) and lineage-specific (rhG-CSF, rhEpo, rhTpo) cytokine administration in SIV-infected rhesus macaques is related to stage of infection.
    Bucur SZ; Gillespie TW; Lee ME; Adams JW; Bray RA; Villinger F; Ansari AA; Hillyer CD
    J Med Primatol; 2000 Apr; 29(2):47-56. PubMed ID: 10950451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine.
    Kawada M; Tsukamoto T; Yamamoto H; Takeda A; Igarashi H; Watkins DI; Matano T
    J Virol; 2007 May; 81(10):5202-11. PubMed ID: 17344296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow monocyte/macrophages are an early cellular target of pathogenic and nonpathogenic isolates of simian immunodeficiency virus (SIVmac) in rhesus macaques.
    Mandell CP; Jain NC; Miller CJ; Dandekar S
    Lab Invest; 1995 Mar; 72(3):323-33. PubMed ID: 7898051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of Cytotoxic CD16+ NK Cells in Simian Immunodeficiency Virus-Infected Lymph Nodes Associated with In Situ Differentiation and Functional Anergy.
    Schafer JL; Li H; Evans TI; Estes JD; Reeves RK
    J Virol; 2015 Jul; 89(13):6887-94. PubMed ID: 25903330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of SIV Nef CD8(+) T cell epitopes restricted by a MHC class I haplotype associated with lower viral loads in a macaque AIDS model.
    Nomura T; Yamamoto H; Takahashi N; Naruse TK; Kimura A; Matano T
    Biochem Biophys Res Commun; 2014 Jul; 450(2):942-7. PubMed ID: 24971540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus SIVmac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques.
    Tsukamoto T; Yuasa M; Yamamoto H; Kawada M; Takeda A; Igarashi H; Matano T
    J Virol; 2007 Nov; 81(21):11640-9. PubMed ID: 17728225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses.
    Bruel T; Hamimi C; Dereuddre-Bosquet N; Cosma A; Shin SY; Corneau A; Versmisse P; Karlsson I; Malleret B; Targat B; Barré-Sinoussi F; Le Grand R; Pancino G; Sáez-Cirión A; Vaslin B
    J Virol; 2015 Apr; 89(7):3542-56. PubMed ID: 25589645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline of simian immunodeficiency virus (SIV)-specific cytotoxic T lymphocytes in the peripheral blood of long-term nonprogressing macaques infected with SIVmac32H-J5.
    Geretti AM; Hulskotte EG; Dings ME; van Baalen CA; van Amerongen G; Norley SG; Boers P; Gruters R; Osterhaus AD
    J Infect Dis; 1999 Oct; 180(4):1133-41. PubMed ID: 10479140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematologic and virologic effects of lineage-specific and non-lineage-specific recombinant human and rhesus cytokines in a cohort of SIVmac239-infected macaques.
    Bucur SZ; Lackey DA; Adams JW; Lee ME; Villinger F; Mayne A; Bray RA; Winton EF; Novembre F; Strobert EA; De Rosayro J; Dailey PJ; Ansari AA; Hillyer CD
    AIDS Res Hum Retroviruses; 1998 May; 14(8):651-60. PubMed ID: 9618076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure to expand influenza and tetanus toxoid memory T cells in vitro correlates with disease course in SIV infected rhesus macaques.
    Ansari AA; Bostik P; Mayne AE; Villinger F
    Cell Immunol; 2001 Jun; 210(2):125-42. PubMed ID: 11520079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-7 treatment counteracts IFN-α therapy-induced lymphopenia and stimulates SIV-specific cytotoxic T lymphocyte responses in SIV-infected rhesus macaques.
    Parker R; Dutrieux J; Beq S; Lemercier B; Rozlan S; Fabre-Mersseman V; Rancez M; Gommet C; Assouline B; Rancé I; Lim A; Morre M; Cheynier R
    Blood; 2010 Dec; 116(25):5589-99. PubMed ID: 20841508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The secretion of IL-22 from mucosal NKp44⁺ NK cells is associated with microbial translocation and virus infection in SIV/SHIV-infected Chinese macaques.
    Wang W; Wu F; Cong Z; Liu K; Qin C; Wei Q
    J Immunol Res; 2014; 2014():387950. PubMed ID: 25759828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macaques with rapid disease progression and simian immunodeficiency virus encephalitis have a unique cytokine profile in peripheral lymphoid tissues.
    Orandle MS; Williams KC; MacLean AG; Westmoreland SV; Lackner AA
    J Virol; 2001 May; 75(9):4448-52. PubMed ID: 11287599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.